Therapeutic Drug Articles & Analysis
48 articles found
Platelet drug delivery systems will use platelets or their derivatives for creating specific drug carriers which can target matching cells to execute drug delivery functions and develop new treatment strategies. Current research directions for this drug system involve the following topics. Platelets Directly Carry ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
These small yet robust molecules present significant advantages in various applications, from therapeutics to diagnostics. This article explores the process of single-domain antibody production, its benefits, and its wide-ranging applications. ...
This article explores the importance of drug screening in drug-resistant cells and its implications for advancing therapeutic strategies. Understanding Drug Resistance Drug resistance occurs when cancer cells or pathogens evolve mechanisms that render them less susceptible to the effects of ...
In the rapidly evolving field of pharmaceuticals, nanotechnology has emerged as a revolutionary force, transforming the landscape of drug delivery and formulation development. The integration of nanotechnology into pharmaceutical formulation offers unprecedented opportunities to enhance the efficacy, safety, and convenience of therapeutic interventions. ...
Compared with small molecular drugs, recombinant protein drugs offer advantages such as high activity, high specificity, and low toxicity, and are therefore favored by researchers. ...
Understanding the complex world of drug discovery and development necessitates familiarity with key players in cellular communication. ...
Ensuring the stability and bioavailability of the drug substance in a liquid environment remains a cornerstone of formulation science, demanding specific expertise and technological know-how. ...
Recombinant protein drugs are protein-based therapeutic drugs which are produced by using DNA recombination technology or other biotechnological methods. These drugs include cytokines, peptide hormones, recombinant enzymes, monoclonal antibodies, and fusion proteins. Compared to traditional low-molecular-weight synthetic ...
Recombinant protein drugs are therapeutic protein drugs produced using DNA recombination technology or other biotechnologies. Compared to traditional low molecular synthetic drugs, they have the advantages of strong specificity, low toxicity, and significant therapeutic effects. ...
The scientific realm behind the development and evaluation of therapeutic drugs, pesticides, industrial and environmental chemicals profoundly relies on a field of research called Pharmacokinetic/Toxicokinetic (PK/TK) studies. ...
Antibody-drug conjugates (ADCs) are a new class of drugs that combine the advantages of both antibodies and small molecule toxins. ...
Difficult to Target Antigens and Novel Drug TargetsDifficult-to-target antigens and novel drug targets are major challenges in antibody discovery and antibody drug design. ...
This step is crucial for ensuring the safety and effectiveness of drugs. Through sequencing technology, potential impurities or mutants can be found and eliminated in time to ensure the consistency and stability of drugs.Biomarker Discovery & Drug Candidate Identification1. ...
Through antibody sequencing, we can understand the differences and characteristics of antibodies between individuals and design antibody drugs that are more suitable for their immune systems, thereby improving therapeutic effects and reducing side effects. 2. ...
Since antibody-drug conjugates (ADCs) have the molecular characteristics of both small molecule and macromolecule therapeutic drugs, when choosing analytical methods, the typical ones used for both should all be considered. There are many different molecules in ADCs, and the difference between these molecules lies in the ...
We devote to accelerate clients' research in the development and manufacture of therapeutic drugs, vaccines, and diagnostics. Plants provide an inexpensive and simple system for the production of valuable recombinant proteins on large scale. ...
By attaching drugs or other therapeutic agents to antibodies that have high selectivity for cancer cells, we can deliver potent treatment directly to the disease site, thereby minimizing systemic side effects. ...
By encapsulating drugs within these microspheres, pharmaceutical companies are able to improve patient compliance, reduce dosing frequency, and enhance therapeutic outcomes. ...
Radioactive drug conjugates (RDCs), as a particular form of coupling drugs, are formed by combining radioactive isotopes with disease-targeting molecules. ...